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TECHNICAL NOTE
A new approach for the surgical management of
unilateral iliac artery occlusive disease: The
iliofemoral crossover transposition
Germano do Carmo, MD, Carlos M. Moura, MD, Carlos Sarmento, MD, Carlos Martins, MD,
Cristina Pestana, MD, Ma´rio Macedo, MD, Anto´nio Rosa, MD, C. Hila´rio Almeida, MD, and
A. Dinis da Gama, MD, PhD, Lisbon, Portugal
Aortobifemoral bypass remains the standard therapy for aortoiliac occlusive disease. Extraanatomic revascularization has
been considered as an acceptable alternative and provides reasonable long-term results. Because some of the causes for its
failure are related to the prosthetic material used, a technique that uses autologous material and is applicable in patients
with unilateral common iliac lesions was developed. Iliofemoral crossover transposition is a femorofemoral bypass
procedure in which the external iliac artery is used as a graft. The procedure is easily performed and avoids the use of
prosthetic materials, minimizing the risks of their related complications. Because its biologic behavior, including
hemodynamic performance, has proven to be excellent, satisfactory long-term results can be anticipated. (J Vasc Surg
2002;36:404-7.)
Notwithstanding developments in technology, con-
cepts, and methods, aortobifemoral bypass remains the
standard therapy for aortoiliac atherosclerotic occlusive
disease because of its high patency rates in the long term
and the low morbidity and mortality rates now associated
with this procedure.1 Nevertheless, in patients at high risk,
or in individuals with a hostile abdomen, axillofemoral or
femorofemoral bypass procedures are also widely and suc-
cessfully performed. All of these procedures involve low
surgical and anesthetic risks and may be accompanied by
satisfactory if not excellent patency rates.2 However, the
use of synthetic materials and their associated complica-
tions can lead to failure in the medium or long term.
The operation known as arterial transposition was car-
ried out for the first time by Blalock and Taussig3 in the
palliative treatment of tetralogy of Fallot (subclavian-pul-
monary transposition). Transposition was later used to
advantage elsewhere in reconstructive vascular surgery, par-
ticularly in the treatment of obstructive disease of the
supraaortic trunks or the visceral arteries of the abdomen.
Femorofemoral bypass is the procedure commonly
used in this setting. The procedure is of recognized value
and generally results in patency rates of more than 60% at 5
years.2,4 Because a significant percentage of failures is re-
lated to the complications associated with the prosthetic
material used, we decided to perform a femorofemoral
bypass with an autologous artery, in the form of a transpo-
sition, for the treatment of unilateral iliac artery occlusive
disease. Herein, we describe the technique of this new
approach to unilateral iliac revascularization.
OPERATION
The operation designated as crossover iliofemoral
transposition consists simply of the implantation of a supra-
pubic femorofemoral bypass, in which the external iliac
artery of the ischemic limb is used as a graft. On the
preoperative angiogram, the external iliac artery is mea-
sured and its length is compared with the distance between
both common femoral arteries to assure that the operation
is feasible.
The femoral bifurcation and the proximal segments of
the superficial and deep femoral arteries of the occluded
side are first isolated. Then, through a small oblique inci-
sion at the level of the iliac fossa, the external iliac artery is
approached retroperitoneally and isolated all along its
length. The exposed iliofemoral segment is carefully as-
sessed to confirm that its length is sufficient for the trans-
position. The origin of the external iliac artery is clamped,
with care taken not to damage the pudendal plexus and to
maintain the integrity of the hypogastric artery. The artery
then is sectioned, and its proximal stump is closed. The
external iliac artery then is completely isolated in a distal
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direction, some collaterals being ligated, and passed be-
neath the inguinal arcade.
After a complete exposure of the common femoral
artery of the patent side, a deep suprapubic tunnel, started
immediately above the level of the common femoral vein
and always at the level of the pubic bone, is created,
through which the previously isolated segment of the il-
iofemoral artery on the occluded side is passed, to be
anastomosed to the common femoral artery on the patent
side, in a terminolateral fashion (Fig 1). When the anasto-
mosis is completed and hemostasis is confirmed, the inci-
sions are closed in layers, in a conventional fashion.
CLINICAL EXPERIENCE
From March 2000 to September 2001, eight individu-
als underwent this type of revascularization (Table). No
blood transfusions were necessary, with the loss of blood
being negligible. The operations had a mean duration of 50
minutes (range, 40 to 75 minutes). Six patients were walk-
ing at 24 hours and were discharged between the 4th and
5th days after the operation. The average in-hospital stay
was 6 days. All of the patients had a significant improve-
ment in ischemic syndromes.
With a mean follow-up period of 14.25 months, all the
grafts remained patent. All grafts were assessed with duplex
scanning at the time of discharge and at 30 days, 3 and 6
months, 1 year, 18 months, and now 23 months. The
evaluations showed normal velocity profiles and amplitude
in all the segments evaluated. No evidence of narrowing or
degeneration of the arterial wall was seen. Peripheral sys-
tolic indices remained comparable with those measured at
the time of discharge, except in one patient, who was
submitted 1 year later to a femoroperoneal bypass, in whom
the indices were further improved. The first four patients
underwent a confirmatory follow-up angiogram (Fig 2).
DISCUSSION
Many different approaches exist for lower limb revas-
cularization in patients with aortoiliac occlusive disease.
Crossover femorofemoral bypass was first described by
Freeman and Leeds5 in 1952. But the era of extraanatomic
revascularization began in earnest in 1962 with the publi-
cation by Vetto6 of the first clinical series of patients who
had undergone successful femorofemoral bypass. After
considerable experimental evaluation and satisfactory clin-
ical results were achieved, the indications for extraanatomic
bypasses were widened and began to be used, even in
individuals with low operative risk.
Fig 1. A, Iliofemoral transposition. B, Sagittal section shows position of graft.
Clinical experience
No. of patients
No. of patients 8
Mean age (years; range) 48.6 (39 to 69)
Male gender 7 (87.50%)
Clinical presentation
Disabling claudication 3 (37.50%)
Rest pain 2 (25%)
Ulceration 3 (37.50%)
Preoperative ankle/brachial indices
0.4 5 (62.50%)
0.55, 0.6 3 (37.50%)
Common iliac lesion
Occlusion 6 (75%)
Preocclusive 2 (25%)
Morbidity and mortality
Retroperitoneal hematoma 1 (12.50%)
Perioperative deaths (30 days) 1* (12.50%)
Patency
Immediate 8 (100%)
Medium and long-term 7
Postoperative ankle/brachial indices
0.65, 0.77 4 (50%)
1.0 4 (50%)
Improvement from limb ischemia 8 (100%)
Mean follow-up (months; range) 14.25 (1 to 23)
*Died in 14th postoperative day of multiple organ failure.
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These techniques have low morbidity and mortality
rates, together with simplicity and ease of execution, which
makes them extremely attractive.7-10 Their hemodynamic
effectiveness has been shown; although compared with
conventional techniques, patency rates depend to a greater
extent on the quality and possible degradation of inflow
and outflow beds. However, in several published series of
femorofemoral bypasses, references to failure of the graft
because of progression of proximal disease are unusual
(Ricco et al11 quote 5.4%; Plecha and Plecha12 report an
incidence rate less than 1%). According to Da Gama,13 the
low incidence rate of progression of obstructive disease in
the donor artery is the result of the fact that because of the
increased flow in this artery, resulting from the reduction in
peripheral resistance, the structure of the artery adapts,
leading to dilatation, which would compensate for possible
future occlusive lesions, thus helping to preserve the revas-
cularization.
A critical factor in the reduced patency rates appears to
be the specific complications inherent on the use of syn-
thetic grafts, like anastomotic fibroplasia, prosthetic infec-
tion, periprosthetic seromas, or anastomotic false aneu-
rysms. An alternative approach intended to avoid these
potential complications would be the use of autologous
veins. However, in femorofemoral positions, few reported
results are found. In addition, the vein frequently is not of
a suitable caliber. Endovascular treatment, besides present-
ing lower medium-term and long-term patency rates in
cases of complete occlusion of the common iliac artery, also
has a high number of immediate failures14-16 and a signif-
icant rate of complications.17
Recently, when faced with a relatively young individual
with critical ischemia of a lower limb as the result of
occlusion of the common iliac artery, we thought to use the
technique of arterial transposition, in the form of a supra-
pubic crossover graft. This has the advantage of not using
synthetic material, it does not necessitate laparotomy and
does not cause sexual dysfunction in male patients. The
ideal substitute of an artery is a healthy artery of the same
individual, preserving all the biochemical and biophysical
properties of a normal artery and providing an excellent
diameter match. It should resist thrombosis, tolerating low
velocity and low flow patterns (as in the cases of a poor
runoff), not cause any significant inflammatory response,
and pose a negligible risk of infection, anastomotic neoin-
timal hyperplasia, or false aneurysm. Theoretically, this
approach should have a higher patency rate when compared
with prosthetic bypasses. With a review of the last 200
consecutive angiograms done in our department, a study of
the anatomy of the arterial tree, and measurement of the
length of the iliac arteries, we found that the procedure
would be feasible in about 82% of the patients, 9% of which
had even excessive external iliac artery length.
In conclusion, iliofemoral crossover transposition is an
often feasible and simple operation to perform and it avoids
synthetic grafts and their potential complications, including
medium-term and long-term failure. The morbidity associ-
ated with this operation, in our experience, has been neg-
ligible, and the single mortality recorded should not be
attributed to the procedure but to the cardiac and renal
impairment of the deceased patient. Although the fol-
low-up period is short, expectation of long-term patency
rates superior to those reported for prosthetic bypass, as
commonly observed for transposition procedures in other
locations, seems reasonable.
We propose that iliofemoral crossover transposition
offers an attractive alternative method of bypass for unilat-
eral occlusive disease of the common iliac artery. Its antic-
ipated durability makes it particularly suited for younger
individuals with a long life expectancy.
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